The IVUS end point was change in percent atheroma volume.

Main outcome measures: The primary efficacy parameter was the percentage change in atheroma volume (follow-up minus baseline).

The secondary efficacy measures were nominal change in normalized total atheroma volume and percentage of patients demonstrating plaque regression.